Antisense Targeting Protein Kinase C α and β1 Inhibits Gastric Carcinogenesis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Protein kinase C (PKC) family, which functions through serine/threonine kinase activity, is involved in signal transduction pathways necessary for cell proliferation, differentiation, and apoptosis. Its critical role in neoplastic transformation and tumor invasion renders PKC a potential target for anticancer therapy. In this study, we investigated the effect of targeting individual PKCs on gastric carcinogenesis. We established gastric cancer cell lines stably expressing antisense PKCα, PKCβ1, and PKCβ2 cDNA. These stable transfectants were characterized by cell morphology, cell growth, apoptosis, and tumorigenicity in vitro and in vivo. PKCα-AS and PKCβ1-AS transfectants showed a different morphology with flattened, long processes and decreased nuclear:cytoplasmic ratio compared with the control cells. Cell growth was markedly inhibited in PKCα-AS and PKCβ1-AS transfectants. PKCα-AS and PKCβ1-AS cells were more responsive to mitomycin C- or 5-fluorouracil-induced apoptosis. However, antisense targeting of PKCβ2 did not have any significant effect on cell morphology, cell growth, or apoptosis. Furthermore, antisense inhibition of PKCα and PKCβ1 markedly suppressed colony-forming efficiency in soft agar and in nude mice xenografts. Inhibition of PKCα or PKCβ1 significantly suppressed transcriptional and DNA binding activity of activator protein in gastric cancer cells, suggesting that PKCα or PKCβ1 exerts their effects on cell growth through regulation of activator protein activity. These data provide evidence that targeting PKCα and PKCβ1 by antisense method is a promising therapy for gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein kinase C and lipid signaling for sustained cellular responses
Nishizuka, Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737456 · Cited by 2,499
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543
Cited by
Protein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker?
Hashimoto, Y., Skacel, M., & Adams, J. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.004 · Cited by 275
Protein kinase C isoforms: Multi-functional regulators of cell life and death
Reyland, M. (2009) · Frontiers in Bioscience · doi:10.2741/3385 · Cited by 266
Protein kinase C (PKC) family in cancer progression
Koivunen, J., Aaltonen, V., & Peltonen, J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.03.033 · Cited by 261
Kim, J. M., Lee, E. K., Kim, D. H., Yu, B. P., & Chung, H. Y. (2010) · AGE · doi:10.1007/s11357-009-9124-1 · Cited by 133
Metadata
- Authors
- Jiang, X.-H., Tu, S.-P., Cui, J.-T., Lin, M. C. M., Xia, H. H. X., Wong, W. M., Chan, A. O.-O., Yuen, M. F., Jiang, S.-H., Lam, S.-K., Kung, H.-F., Soh, J. W., Weinstein, I. B., & Wong, B. C.-Y.
- Venue
- Cancer Research
- Published
- 2004-08-15
- Volume
- 64
- Issue
- 16
- Pages
- 5787-5794
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2059260058
- Cited by
- 59
- References
- 2
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antisense Targeting Protein Kinase C α and β1 Inhibits Gastric Carcinogenesis. https://app.cochat.ai/papers/10.1158/0008-5472.can-03-1172
- The paper
- Jiang, X.-H., Tu, S.-P., Cui, J.-T., Lin, M. C. M., Xia, H. H. X., Wong, W. M., Chan, A. O.-O., Yuen, M. F., Jiang, S.-H., Lam, S.-K., Kung, H.-F., Soh, J. W., Weinstein, I. B., & Wong, B. C.-Y. (2004). Antisense Targeting Protein Kinase C α and β1 Inhibits Gastric Carcinogenesis. Cancer Research. https://doi.org/10.1158/0008-5472.can-03-1172
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.